- Report
- April 2023
- 120 Pages
Spain
From €4323EUR$4,750USD£3,672GBP
- Report
- April 2023
- 80 Pages
Germany
From €4323EUR$4,750USD£3,672GBP
- Report
- July 2022
- 57 Pages
Global
From €3641EUR$4,000USD£3,092GBP
- Report
- October 2021
- 90 Pages
Global
From €3641EUR$4,000USD£3,092GBP
- Report
- September 2024
- 66 Pages
Argentina
From €2503EUR$2,750USD£2,126GBP
- Report
- March 2025
- 87 Pages
Global
From €3500EUR$4,119USD£3,077GBP
- Report
- July 2024
- 95 Pages
Global
From €3500EUR$4,119USD£3,077GBP
- Report
- November 2023
- 119 Pages
Global
From €3500EUR$4,119USD£3,077GBP
- Report
- October 2023
- 91 Pages
Global
From €3500EUR$4,119USD£3,077GBP
- Report
- January 2023
- 256 Pages
Global
From €2275EUR$2,499USD£1,932GBP
€3249EUR$3,570USD£2,760GBP
- Book
- March 2019
- 648 Pages
- Book
- July 2010
- 136 Pages

Prenatal Diagnostics is a branch of diagnostics that focuses on the detection of genetic and chromosomal abnormalities in a fetus. It is used to identify potential health risks to the fetus and mother, and to provide information for parents to make informed decisions about their pregnancy. Prenatal Diagnostics can be used to detect a wide range of conditions, including Down Syndrome, cystic fibrosis, and neural tube defects. It can also be used to detect genetic disorders that may be inherited from the parents.
Prenatal Diagnostics is typically performed through a variety of tests, such as amniocentesis, chorionic villus sampling, and non-invasive prenatal testing. These tests can be used to detect genetic abnormalities, chromosomal abnormalities, and other conditions.
Some companies in the Prenatal Diagnostics market include Illumina, Inc., Natera, Inc., PerkinElmer, Inc., and Sequenom, Inc. Show Less Read more